Search Login Register

Ameloblastoma Summary

Description: An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.

Also Known As: Ameloblastomas

Networked: 658 relevant articles (4 outcomes, 142 trials/studies) for this Disease

Key Drugs and Agents for Ameloblastoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antibodies : 1 outcome 4 studies in 35 results : IBA
  2. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 1 outcome 4 studies in 8 results : IBA
  3. Protein Kinases (Protein Kinase) : 1 outcome in 5 results : IBA
  4. Adenoameloblastoma : 9 studies in 53 results : IBA
  5. Proliferating Cell Nuclear Antigen (PCNA) : 9 studies in 19 results : IBA
  6. Paraffin : 8 studies in 46 results : IBA
  7. Messenger RNA (mRNA) : 8 studies in 34 results : IBA
  8. DNA (Deoxyribonucleic Acid) : 6 studies in 19 results : IBA
  9. Keratins (Keratin) : 5 studies in 31 results : IBA
  10. Proteins (Proteins, Gene) : 4 studies in 26 results : IBA
Show All >>

Diseases Related to Ameloblastoma

  1. Odontogenic Cysts (Keratocyst)
  2. Ameloblastoma
  3. Neoplasms (Cancer)
  4. Odontogenic Tumors (Dental Tissue Neoplasm)
  5. Dentigerous Cyst
Show All >>

Key Therapies for Ameloblastoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome in 8 results
  2. Aftercare (After-Treatment) : 1 outcome in 6 results
  3. Oral Pathology : 5 studies in 16 results
  4. Oral Surgery (Maxillofacial Surgery) : 4 studies in 12 results
  5. Transplants (Transplant) : 3 studies in 49 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.